Ixmyelocel-T

Ixmyelocel-T · Vericel Corporation

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Ixmyelocel-T, covering 2019-10-21 to 2021-05-27. Get the full timeline:

Most recent: Clinical Trial Update: An Efficacy and Safety Study of Ixmyelocel-T in Patients With Critical Limb Ischemia (CLI) [Phase 3]